The world of finance, connected.EN / Global
PF
CompanyCompany profileReviewed 2026-10-23

PFIZER INC

Pfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.

Sources and references ↗
COMPANY PROFILE / 20 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Ticker / security symbols
PFE [1]
Listing exchanges
NYSE [1]
SEC industry
Pharmaceutical Preparations [1]
Business sectors
pharmaceutical industry [2]
Company / filing name
PFIZER INC [1]
Headquarters location
New York City [2]
Business address
66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192 [1]
Founded
1849 [2]
Legal form
public company; Delaware corporation [2]
Incorporation jurisdiction
Delaware, United States [1]
Leadership in background record
Albert Bourla [2]
Founders
Charles F. Erhart; Charles Pfizer [2]
Official website
www.pfizer.com ↗ [2]
Employees
78,500 · reported year 2020 [2]
Annual revenue
USD 63,627,000,000 · reported year 2024 [2]
Fiscal year end
December 31 (SEC record) [1]
ISIN (reported securities)
US7170811035 [2]
CIK
0000078003 [1]
SIC code
2834 [1]
Country in background record
United States [2]

Company positioning and business

Pfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. [3]

Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis (apixaban) ($7.9 billion in 2025 revenues, 13% of total revenues), Prevnar (a pneumococcal conjugate vaccine) ($6.5 billion in 2025 revenues, 10% of total revenues), Paxlovid (Nirmatrelvir/ritonavir) ($2.4 billion in 2025 revenues, 4% of total revenues), Vyndaqel (tafamidis) ($6.4 billion in 2025 revenues, 10% of total revenues), Comirnaty (the Pfizer–BioNTech COVID-19 vaccine) ($4.4 billion in 2025 revenues, 7% of total revenues), and Ibrance (palbociclib) ($4.1 billion in 2025 revenues, 7% of total revenues). In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. [3]

The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. [3]

Background text: Wikipedia contributors, Pfizer. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Management and corporate governance

The Wikidata background record identifies Albert Bourla in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]

Understanding company scale

Employees: 78,500 · reported year 2020. [2]

Annual revenue: USD 63,627,000,000 · reported year 2024. [2]

Financial year, securities and disclosures

The SEC submissions record gives PFIZER INC a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]

Listed securities: PFE (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]

History and key events

  1. Founding / inception date recorded in Wikidata. [2]

  2. Form 10-K filed; reporting period ends 2025-12-31. [5]

Financial results and regulatory disclosures

Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.

Source-verified relationships

PFIZER INC → Listed on → NYSE [1]
PFIZER INC → SEC industry classification → Pharmaceutical Preparations [1]

Companies in the same industry

Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.

Related entities and concepts

Frequently asked questions

When was PFIZER INC founded?

Founded: 1849. The linked source provides the background record. [2]

Where is the headquarters of PFIZER INC?

Headquarters location: New York City. The linked source provides the background record. [2]

Which business sectors are recorded for PFIZER INC?

Business sectors: pharmaceutical industry. The linked source provides the background record. [2]

RELATION MAP

PFIZER INC relationship map

Drag to rotate · Scroll to zoom
PFIZER INC

Select a node to inspect its relationship and source.

2 verified direct relationships. Industry peers are not relationship edges.

Sources and review dates

  1. SEC — PFIZER INC filing identity and securities ↗
  2. Wikidata — company background record (CC0) ↗
  3. Wikipedia contributors — Pfizer (CC BY-SA 4.0) ↗
  4. SEC securities directory ↗
  5. Company chronology / filing ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.